Showing 15,281 - 15,300 results of 107,116 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 15281
  2. 15282
  3. 15283
  4. 15284
  5. 15285

    Effect of telomerase siRNA transfection on AFP production by HepG2/C3A and PLC/PRF/5 cells. by Roula Tahtouh (714734)

    Published 2015
    “…(A) The inhibition of telomerase by hTERT siRNA induced a decrease in AFP production by HepG2/C3A cells. …”
  6. 15286
  7. 15287

    Exploration of the Singlet O<sub>2</sub> Oxidation of 8‑Oxoguanine by Guided-Ion Beam Scattering and Density Functional Theory: Changes of Reaction Intermediates, Energetics, and K... by Yan Sun (22436)

    Published 2017
    “…Measurements include the effects of collision energy (<i>E</i><sub>col</sub>) on reaction cross sections over a center-of-mass <i>E</i><sub>col</sub> range from 0.1 to 0.5 eV. …”
  8. 15288
  9. 15289

    Recruitment of α5-GABA<sub>A</sub>Rs to PV-synapses contributes to wake-dependent enhancement of iLTP. by Kunwei Wu (725668)

    Published 2022
    “…(K) Representative PV-IPSC traces at indicated time points in (J). (L) L655,708 decreased the potentiation of PV-IPSC amplitude after NMDA application in wake and sleep-deprived mice (SD) but not sleep mice (<i>n</i> = 7–8, 2-way ANOVA, F (4, 38) = 4.234, <i>p</i> = 0.0062 with Sidak’s multiple comparison test, Sleep a versus Sleep b, <i>p</i> = 0.028; Sleep a versus Sleep c, <i>p</i> = 0.04; Wake a versus Wake b, <i>p</i> = 0.0014; Wake b versus Wake c, <i>p</i> = 0.023; Wake a versus Wake c, <i>p</i> = 0.0008; SD a versus SD b, <i>p</i> < 0.0001; SD b versus SD c, <i>p</i> = 0.0091; SD a versus SD c, <i>p</i> = 0.0002; Sleep b versus Wake b, <i>p</i> = 0.028; Sleep b versus SD b, <i>p</i> = 0.04). …”
  10. 15290

    Image_1_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  11. 15291

    Image_3_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  12. 15292

    Image_2_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  13. 15293

    Colocalization of pDNA with Rab5. by Lisa D. Cervia (3737431)

    Published 2017
    “…The light (L) treated group showed a significant decrease in the colocalization of pDNA with Rab5, compared to the no light (NL) treated group. …”
  14. 15294

    Data Sheet 1_Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease.xlsx by Demos Kynigopoulos (12420457)

    Published 2025
    “…</p>Methods<p>We investigated the effects of two FDA-approved metabolic agents—Alirocumab, a PCSK9 inhibitor that lowers LDL cholesterol, and Gliclazide, a sulfonylurea that enhances insulin secretion—in male 5xFAD mice, a transgenic model of AD. …”
  15. 15295

    Supplementary file 1_Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease.docx by Demos Kynigopoulos (12420457)

    Published 2025
    “…</p>Methods<p>We investigated the effects of two FDA-approved metabolic agents—Alirocumab, a PCSK9 inhibitor that lowers LDL cholesterol, and Gliclazide, a sulfonylurea that enhances insulin secretion—in male 5xFAD mice, a transgenic model of AD. …”
  16. 15296

    Glial 5-HT<sub>2a</sub> receptors are necessary and rate limiting for experience-dependent synaptic glomeruli pruning. by Vanessa Kay Miller (19775496)

    Published 2024
    “…The Or42a OSN innervation volume with glial <i>5-HT</i><sub><i>2A</i></sub><i>R</i> OE is very significantly decreased in comparison to the control EB condition (<i>p</i> = 4.64 × 10<sup>−10</sup>). …”
  17. 15297
  18. 15298
  19. 15299
  20. 15300